Quarterly report pursuant to Section 13 or 15(d)

LICENSES ACQUIRED (Details)

v3.21.2
LICENSES ACQUIRED (Details) - USD ($)
$ in Thousands
Jun. 29, 2021
Sep. 30, 2021
Dec. 31, 2020
Licenses acquired      
Second installment payable   $ 7,972 $ 12,659
D F D Agreement      
Licenses acquired      
Amount payable $ 10,000 10,000  
First installment paid 2,000    
Second installment payable $ 8,000    
Period within which second installment is payable 90 days    
Amount payable to fund clinical trials   $ 24,000  
D F D Agreement | Minimum      
Licenses acquired      
Percentage of royalties payable on net sales 10.00%    
D F D Agreement | Maximum      
Licenses acquired      
Threshold additional contingent regulatory and commercial milestone payments payable $ 163,000    
Percentage of royalties payable on net sales 15.00%